RNF213 and Moyamoya disease: Following the initial discovery, a genome-wide association study in Japanese patients with moyamoya disease revealed that 95% of familial and 73% of non-familial patients carried the RNF213 p.Arg4810Lys variant, which conferred an odds ratio of 190.8 for the disease [83].